T0	Gene-Protein 30 33	APN
T1	Gene-Protein 269 272	APN
T10	Disease 683 688	NAFLD
#3	AnnotatorNotes T10	DOID:0080208
T11	Disease 754 759	NAFLD
T13	Disease 864 872	diabetic
T14	Gene-Protein 1041 1044	APN
T15	Disease 1048 1066	T1DM-induced NAFLD
#7	AnnotatorNotes T15	not found
T17	Gene-Protein 1127 1130	APN
T18	Disease 1141 1159	T1DM-induced NAFLD
T2	Chemical 303 310	glucose
T21	Gene-Protein 1262 1265	APN
T22	Disease 1303 1321	T1DM-induced NAFLD
T3	Drug 353 355	AS
#16	AnnotatorNotes T3	C553926
T4	Chemical 387 394	glucose
T6	Gene-Protein 423 426	APN
T8	Chemical 497 512	free fatty acid
#1	AnnotatorNotes T0	HGNC:13633
T7	Disease 329 337	diabetic
#2	AnnotatorNotes T7	not found
T5	Gene-Protein 449 476	cannabinoid type 1 receptor
#6	AnnotatorNotes T5	HGNC:2159
T9	Gene-Protein 622 625	APN
T12	Biomarker 613 625	level of APN
R1	Risk-Reduce Arg1:T12 Arg2:T10	
R2	Association Arg1:T12 Arg2:T11	
T20	Gene-Protein 792 795	APN
T24	Gene-Protein 814 817	APN
T25	Biomarker 786 856	serum APN level and hepatic APN expression were also significantly low
R3	Association Arg1:T25 Arg2:T13	
T16	Drug 1127 1130	APN
R4	Response Arg1:T16 Arg2:T18	
T19	Gene-Protein 1195 1200	FoxO1
#5	AnnotatorNotes T19	HGNC:3819
T26	Biomarker 1164 1200	reduction of the expression of FoxO1
T27	Gene-Protein 1212 1216	Akt1
#8	AnnotatorNotes T27	HGNC:391
T23	Gene-Protein 1294 1299	FoxO1
T28	GeneFamily 52 61	adipokine
#10	AnnotatorNotes T28	not found
T29	Drug 1041 1044	APN
#4	AnnotatorNotes T29	D052242
R5	Response Arg1:T29 Arg2:T15	
